U.S. Markets closed

With Pfizer Firmly in Value Territory, Here's What Investors Are Missing

With Pfizer Firmly in Value Territory, Here's What Investors Are Missing

The stock is already down about 15% in 2023 as the pharmaceutical giant gets set to report earnings.